Group items matching

in title, tags, annotations or url

Understanding the healthcare industry structure can help in gaining an insight into the changing needs of its affiliated IT market. The healthcare industry consists of three major participants - the providers, the payors, and the consumers. As the overall industry is moving towards integration, an insight into each participant's needs could help system providers design overarching systems that simultaneously cater to all the unmet requirements.

The global medical image analysis market is growing at a higher rate as compared to the equipment market. The image analysis software market is driven by higher demand for diagnostic procedures globally, technology improvements and demand from the consumer end. The major restraints are the inherent drawbacks associated with software. The major trends seen in the market are towards open source software, online portals and 30 day trials for software. The major challenges from the end-users are restriction in terms of software usage and major challenge for standalone vendors is the OEM manufacturers.

The global prepacked chromatography columns market is segmented on the basis of type, end user, and geography. Based on geography, this market is segregated into North America, Europe, Asia-Pacific, and rest of the world. In 2014, North America is estimated to dominate the global market, followed by Asia-Pacific and Europe.

The global cell counting market is mainly dominated by six players that accounted for around 65% to 70% of the global market share in 2014. However, new players in the market are intensifying competition and thereby threatening the market share of the existing players. In order to maintain their shares, leading players are continuously adopting various strategies. This increased competitiveness is expected to drive innovation in the market and thereby help the industry to solve the existing challenges.

The report extensively covers the healthcare provider IT and payer IT markets. The market in this report has been segmented on the basis of its applications, delivery modes, and components. Based on applications, the healthcare information technology is segmented into provider (clinical information technology and non-clinical information technology) and payer, while the market by delivery mode is further categorized as on-premises, web-based, and cloud-based.

The top five players in the global optical imaging market accounted for over 80% of the market share. However, the intense competition by existing small- and mid-sized players in the market is threatening the market share of top players. In order to maintain their share, leading players are continuously embracing new technologies and striving to bring advanced products into the market. This increasing competitiveness is also expected to drive innovation in the market, thereby helping the industry to solve existing challenges and meet the needs of the market.

North America dominated the market, with the U.S. accounting for a major market share. Asia is poised to grow at the highest CAGR during the forecast period. The large share of the North American market can be attributed to factors such as rising incidences of chronic diseases, expanding biotechnology and pharmaceutical industries, government support, and the launch of new products in the region.

The global catheter stabilization device market is expected to reach $1,372.35 Million by 2020 from $957.26 Million in 2015, growing at a CAGR of 7.47% between 2015 and 2020. Securement devices are used to secure catheters and infusion or drainage devices and to facilitate their operations. They can be repositioned upon initial application unlike normal dressing tapes, and are water-resistant devices made of latex-free, soft-cloth materials and are water resistant. The scope of the catheter stabilization device market includes securement devices used in surgeries and home healthcare settings.

The global sleep apnea devices market is dominated by North America, followed by Europe, Asia, and Rest of the World (RoW). North America will continue to lead the sleep apnea device market in the years to come, followed by Europe. As reimbursement policies become more consistent across European countries, sustained steady growth is expected from the region in the coming years. The Asian region's contribution to the global sleep apnea device market is expected to pick up in the coming years as the medical condition gets more recognition from both patients and the medical fraternity alike.

The antibody production market is segmented on the basis of products, types, technologies, applications, and end users. The increasing demand for monoclonal antibodies globally and rising R&D expenditure of pharmaceutical and biotechnology companies are major factors driving this market. Moreover, emerging markets of India and China, rising demand for protein therapeutics, and increasing risk of pandemics and infectious diseases are likely to increase the demand for equipment and consumables used in antibody production. However, high cost of primary antibodies is likely to restrain the growth of this market

The antibody production market is segmented on the basis of products, types, technologies, applications, and end users. The increasing demand for monoclonal antibodies globally and rising R&D expenditure of pharmaceutical and biotechnology companies are major factors driving this market. Moreover, emerging markets of India and China, rising demand for protein therapeutics, and increasing risk of pandemics and infectious diseases are likely to increase the demand for equipment and consumables used in antibody production. However, high cost of primary antibodies is likely to restrain the growth of this market

The veterinary software market by product type is divided into practice management software and veterinary imaging software. The veterinary practice management software helps veterinarians in appointment management, billing & invoicing, boarding management, patient records, prescription labeling, reminders, and treatment management. The veterinary imaging segment includes standalone digital imaging software used for X-ray CT, MRI, ultrasound and other digital imaging in clinics/ hospitals and laboratories.

As of 2014, Agilent Technologies, Inc. (U.S.) held the leadership position in the global market. Over the past three years, the company adopted new product launches and strategic acquisitions as its key business strategies to ensure its dominant position in this market. In addition, TE Connectivity Ltd. (Switzerland), Danaher Corporation (U.S.), E.S.I. Environment Sensors Inc. (Canada), Honeywell International, Inc. (U.S.), Lockheed Martin Corporation (U.S.), Ball Aerospace and Technologies Corporation (U.S.), The Raytheon Company (U.S.), Siemens AG (Germany), and Thales Group (France) are some of the other key players in this market.

North America dominated the market in 2013 and will continue to drive and dominate it by 2018. However, the market share of this region will decrease to 34.5%, primarily due to the sequestration cuts announced in the U.S., which have resulted in lower investments from the government in research activities supporting proteomics. At the same time, Asia and Latin America are poised to grow at a CAGR of 17% to 22% in the forecast period; this growth is largely driven by the growing research base in these regions and the increasing pharmaceutical research related to drug discovery and drug development, and diagnostics product development activities in these regions.

The major players in the market include Oracle Corporation (U.S), Medidata Solutions, Inc. (U.S), BioClinica, Inc. (U.S), OmniComm Systems, Inc. (U.S), PAREXEL International Corp. (U.S), DATATRAK International, Inc. (U.S), AG Mednet, Inc. (U.S), Merge Healthcare Incorporated (U.S), PHT Corporation (U.S), eResearch Technology, Inc. (U.S), and CRF Health (U.S).

The major players in the market include Oracle Corporation (U.S), Medidata Solutions, Inc. (U.S), BioClinica, Inc. (U.S), OmniComm Systems, Inc. (U.S), PAREXEL International Corp. (U.S), DATATRAK International, Inc. (U.S), AG Mednet, Inc. (U.S), Merge Healthcare Incorporated (U.S), PHT Corporation (U.S), eResearch Technology, Inc. (U.S), and CRF Health (U.S).

This research report categorizes and analyzes the global next generation sequencing market on the basis of steps in the NGS workflow and applications. These markets are further divided into segments and sub-segments, to provide exhaustive value analysis for the years 2012, 2013, and 2014 forecast to 2020. Each market is comprehensively analyzed at a granular level by geography (North America, Europe, Asia, and Rest of the World) to provide in-depth information on the global scenario.

The key players in the immunoassay market include Roche Diagnostics (Switzerland), Siemens Healthcare (Germany), Abbott Laboratories (U.S.), Beckman Coulter (U.S.), Ortho Clinical Diagnostics (U.S.), and bioMérieux (France).

The product segments in the medical aesthetics market are dominated by various players, depending on their core competencies. In 2014, Cynosure Inc., Syneron Medical Ltd., Solta Medical, Inc., ZELTIQ Aesthetics, Inc., Lumenis Ltd., and PhotoMedex, Inc. were the leading companies in the global medical aesthetics laser and energy devices market. Moreover, in 2014, Allergan, Inc., Galderma S.A., and Merz Aesthetics, Inc. were the leading players in the global facial aesthetics market. The breast implants market was dominated by Allergan, Inc. and Mentor Corporation in 2014.

Participating hospitals reduced mortality among sepsis patents during the study period by 44 percent, 1-year poststudy mortality decreased by 54.5 percent, and the initiative has generated a positive return on investment.

Since program implementation, the rates of ventilator-associated pneumonia, central line infections and pressure ulcers have decreased, intensive care unit (ICU) readmissions have declined, ICU length of stay remains low, and testing and pain management education have increased.